Skip to main content
Premium Trial:

Request an Annual Quote

GNF Renews License to Ingenuity's Pathways Analysis Software

NEW YORK (GenomeWeb News) - Ingenuity Systems today said that the Genomics Institute of the Novartis Research Foundation has renewed and expanded a licensing agreement for its pathway analysis software.
 
The licensing deal grants GNF continued use of Ingenuity's Pathway Analysis software for the institute's research in RNA profiling, Ingenuity said. GNF originally licensed the software in 2003.
 
IPA is designed for pathway modeling and analysis in biomarker, toxicology, and pharmacogenomics research.
 
Financial terms of the agreement were not released.

Filed under

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.